Herzog, Rebecca
Kuster, Lilian
Becker, Julia
Gluexam, Tobias
Pils, Dietmar
Spittler, Andreas
Bhasin, Manoj K.
Alper, Seth L.
Vychytil, Andreas
Aufricht, Christoph
Kratochwill, Klaus http://orcid.org/0000-0003-0803-614X
Article History
Received: 16 February 2017
Accepted: 5 June 2017
First Online: 24 July 2017
Competing Interests
: C.A. is cofounder of Zytoprotec GmbH, a spin-off of the Medical University Vienna that holds the patent ‘Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue’ (International Publication Number: WO 2008/106702 A1). R.H., L.K. and K.K. are former employees of Zytoprotec GmbH. A.V. has received consulting and lecture fees from Baxter, Fresenius Medical Care and Amgen, travel funding/congress fees from Baxter and Fresenius Medical Care and Research funding from Baxter (all unrelated to this trial). He has been a principal investigator in trials funded by Baxter, Fresenius and Zytoprotec. All other authors declare no competing financial interests.